非经营性资金占用及其他关联资金 往来情况专项说明 安徽皖仪科技股份有限公司 容诚专字[2025]230Z0932 号 容诚会计师事务所(特殊普通合伙) 中国·北京 关于安徽皖仪科技股份有限公司 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 非经营性资金占用及其他关联资金往来情况专项说明 容诚专字[2025]230Z0932 号 容诚会计师事务所 （特殊普通合伙） 中国注册会计师： 孔晶晶 安徽皖仪科技股份有限公司全体股东： 我们接受委托，依据中国注册会计师审计准则审计了安徽皖仪科技股份有限 公司（以下简称皖仪科技）2024 年 12 月 31 日的合并及母公司资产负债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表和合并及母公司所有者权 益变动表以及财务报表附注，并于 2025 年 4 月 28 日出具了容诚审字 [ ...

募集资金存放与实际使用情况鉴证报告 安徽皖仪科技股份有限公司 容诚专字[2025]230Z0931 号 容诚会计师事务所(特殊普通合伙) 中国·北京 目 录 | 序号 | 内 容 | 页码 | | --- | --- | --- | | 1 | 募集资金存放与实际使用情况鉴证报告 | 1-2 | | 2 | 募集资金存放与实际使用情况的专项报告 | 3-8 | 募集资金存放与实际使用情况鉴证报告 容诚专字[2025]230Z0931 号 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 安徽皖仪科技股份有限公司全体股东： 我们审核了后附的安徽皖仪科技股份有限公司（以下简称皖仪科技）董事会编 制的 2024 年度《募集资金存放与实际使用情况的专项报告》。 一、 对报告使用者和使用目的的限定 本鉴证报告仅供皖仪科技年度报告披露之目的使用， ...

内部控制审计报告 安徽皖仪科技股份有限公司 容诚审字[2025]230Z1314 号 容诚会计师事务所(特殊普通合伙) 中国·北京 内部控制审计报告 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 容诚审字[2025]230Z1314 号 安徽皖仪科技股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了安徽皖仪科技股份有限公司（以下简称皖仪科技）2024 年 12 月 31 日的 财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是皖仪 科技董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计意见，并对注意到的非财务报告内部控制 ...

2024 年度营业收入扣除情况的 专项审核报告 安徽皖仪科技股份有限公司 容诚专字[2025]230Z1329 号 容诚会计师事务所(特殊普通合伙) 中国·北京 | | | | 序号 | 内 | 容 | 页码 | | --- | --- | --- | --- | | 1 | 营业收入扣除情况的专项审核报告 | | 1-2 | | 2 | 营业收入扣除情况表 | | 3 | 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 关于安徽皖仪科技股份有限公司 2024 年度营业收入扣除情况的专项审核报告 容诚专字[2025]230Z1329 号 安徽皖仪科技股份有限公司全体股东： 我们接受委托，按照中国注册会计师审计准则审计了安徽皖仪科技股份有限 公司（以下简称皖仪科技）2024 年度财务报表，并于 2025 年 4 月 28 日出具了容 ...

安徽天禾律师事务所 法律意见书 关于安徽皖仪科技股份有限公司 ANHUI TIANHE LAW OFFICE 地址：合肥市濉溪路 278 号财富广场 B 座东楼 16 层 电话：（0551）62642792 传真：（0551）62620450 1 2021 年限制性股票激励计划作废处理部分限制性股票 之 法律意见书 安徽天禾律师事务所 法律意见书 安徽天禾律师事务所 关于安徽皖仪科技股份有限公司 2021 年限制性股票激励计划作废处理部分限制性股票 之法律意见书 天律意 2025 第 00910 号 致：安徽皖仪科技股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国 公司法》（以下简称"《公司法》"）、中国证券监督管理委员会（以下简称"证监 会"）《上市公司股权激励管理办法》（以下简称"《管理办法》"）《上海证券交易 所科创板股票上市规则》（以下简称"《上市规则》"）及《科创板上市公司自律监 管指南第 4 号——股权激励信息披露》（以下简称"《披露指南》"）等法律、 行政法规、部门规章及规范性文件（以下统称"法律法规"）和《安徽皖仪科技 股份有限公司章程》（以下简称"《公司 ...

Financial Performance - The company's operating revenue for 2024 was CNY 740.32 million, a decrease of 5.92% compared to CNY 786.87 million in 2023[25]. - The net profit attributable to shareholders for 2024 was CNY 14.41 million, down 67.11% from CNY 43.81 million in 2023[25]. - The cash flow from operating activities for 2024 decreased by 66.96% to CNY 32.19 million, compared to CNY 97.42 million in 2023[25]. - Basic earnings per share for 2024 were CNY 0.11, a decline of 66.67% from CNY 0.33 in 2023[26]. - The company's total assets at the end of 2024 were CNY 1.20 billion, down 8.93% from CNY 1.32 billion at the end of 2023[25]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY -1.97 million in 2024, a decline of 107.95% from CNY 24.85 million in 2023[25]. - The company's gross profit margin decreased by 2.09 percentage points to 45.60% compared to the previous year[102]. - The company reported a significant decline in sales volume for industrial detection instruments, down 25.87% year-on-year, influenced by reduced demand in the new energy market[104]. - The online monitoring instruments saw a sales volume decrease of 22.08% year-on-year, attributed to intense market competition[104]. Research and Development - Research and development expenses accounted for 19.82% of operating revenue in 2024, a decrease of 1.33 percentage points from 21.15% in 2023[26]. - The total R&D investment for the year was approximately ¥146.77 million, a decrease of 11.81% compared to the previous year[74]. - The company continues to maintain a high level of R&D investment, impacting short-term profits but aimed at long-term growth[28]. - The company has established a first-class R&D team with expertise across various fields, enhancing R&D efficiency and innovation capabilities[87]. - The company has developed core technologies including ultra-low emission online monitoring technology and volatile organic compounds (VOCs) analysis technology, which are at the product stage and are domestically leading[67]. - The company has developed advanced technologies such as high-reliability sealing and decomposition devices, and various detection technologies, all of which are at the product stage[68]. - The company has made significant advancements in software technologies, including cloud-native applications and deep learning intelligent analysis technologies, all leading domestically[68]. - The company is focusing on continuous R&D investment and innovation to meet the high standards required for precision instruments, which have significant technical barriers to entry[55]. Market Strategy and Expansion - The company is focusing on expanding its market presence in 23 countries, including Ecuador, Peru, and Mexico, to enhance its international competitiveness[42]. - The company is actively participating in the Guangdong Alliance bulk procurement for ultrasonic knives, aiming to strengthen its market position in the medical device sector[41]. - The company is focusing on expanding its market presence in the semiconductor and new energy sectors, with significant growth potential anticipated in the coming years[79]. - The company is committed to becoming a competitive player in the precision scientific instruments and life health sectors, with a vision of being a respected Chinese enterprise[132]. - The company is strategically positioned for future growth through its investment in new technologies and market expansion efforts[152]. Corporate Governance - The company has established a comprehensive governance structure in compliance with relevant laws and regulations, ensuring effective operation and accountability[140]. - The independent directors actively participated in decision-making, enhancing the board's professionalism and efficiency[141]. - The company has no significant issues regarding independence from its controlling shareholders, maintaining a clear separation in operations and finances[143]. - The company’s governance practices align with the standards set by the China Securities Regulatory Commission and the Shanghai Stock Exchange[143]. - The company held 6 board meetings during the year, with 5 conducted via communication methods and 1 combining on-site and communication methods[162]. Shareholder Engagement and Profit Distribution - The company plans to distribute a cash dividend of 1.00 CNY per 10 shares for the 2024 fiscal year, amounting to approximately 12,532,241.10 CNY, which accounts for 86.99% of the projected net profit attributable to shareholders[180][183]. - The cumulative cash dividend over the last three fiscal years amounts to 65,118,805.90 CNY, with an average net profit of 35,342,918.44 CNY, resulting in a cash dividend ratio of 184.25%[185]. - The company has maintained a robust communication process with minority shareholders regarding profit distribution proposals[181]. - The company ensures that independent directors fulfill their responsibilities and that minority shareholders have opportunities to express their opinions on profit distribution[181]. Financial Position and Investments - The company reported a significant improvement in operational efficiency, contributing to a 46.18% increase in the financial director's shareholding[150]. - The company's cash and cash equivalents increased by 73.45% to 88.28 million yuan, primarily due to the recovery of financial products[115]. - The company's investment activities generated a net cash flow of 77.64 million yuan, a significant increase compared to the previous year's negative cash flow[113]. - The company has a strong after-sales service team, enhancing market competitiveness and customer satisfaction[86]. - The company is exposed to financial risks if government support for its industry decreases, potentially affecting its operating performance[92]. Talent Development and Employee Engagement - The company is committed to talent development, optimizing its workforce structure and enhancing its training systems to attract and retain talent[46]. - The company has established a competitive salary system based on performance evaluation, ensuring key talents are compensated favorably in the market[171]. - A training plan for 2024 is in place, focusing on new hires and existing employees, with specialized training for key positions to ensure competency[172]. - The overall employee engagement in stock ownership has risen, with a notable 34.22% increase for Wei Binsong, indicating a positive shift in company culture[150]. Risk Management - The company has detailed various risks and countermeasures in the report, which can be found in the "Risk Factors" section[4]. - The company faces risks related to market demand fluctuations due to macroeconomic conditions, which may impact future revenue growth[91]. - The company is focusing on maintaining a high proportion of R&D investment, which has led to a negative taxable income in recent years[97].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 134,286,929.36, representing a 16.87% increase compared to CNY 114,906,354.26 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 5,450,922.09, an improvement from a loss of CNY 33,616,386.19 in the previous year[4] - The basic and diluted earnings per share were both negative CNY 0.04, an improvement from negative CNY 0.25 in the same period last year[4] - Net profit for Q1 2025 was -¥5.45 million, an improvement from -¥33.62 million in Q1 2024, indicating a significant reduction in losses[20] Cash Flow - The net cash flow from operating activities was a negative CNY 24,458,924.76, worsening from a negative CNY 14,945,672.69 year-on-year[4] - Cash flow from operating activities showed a net outflow of -¥24.46 million in Q1 2025, compared to -¥14.95 million in Q1 2024[24] - Cash inflow from investment activities was ¥115.89 million in Q1 2025, a decrease from ¥206.91 million in Q1 2024[24] - Cash outflow from investment activities totaled ¥133.05 million in Q1 2025, down from ¥149.18 million in Q1 2024[24] - The net increase in cash and cash equivalents was -$28,976,358.19, a significant decline from an increase of $54,317,165.21 in the prior period[25] - The ending balance of cash and cash equivalents was $56,241,866.39, down from $104,036,896.49, representing a decrease of approximately 46.0%[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,179,462,076.18, a decrease of 1.86% from CNY 1,201,819,195.09 at the end of the previous year[5] - The equity attributable to shareholders decreased by 6.68% to CNY 739,360,356.23 from CNY 792,297,427.81[5] - Total liabilities increased to ¥440.10 million in the latest reporting period from ¥409.52 million previously, indicating a rise in financial obligations[17] - Current liabilities decreased to RMB 353,429,580.57 from RMB 376,336,646.15, showing a reduction of approximately 6.06%[16] Research and Development - Research and development expenses totaled CNY 35,440,733.04, down 19.06% from CNY 43,785,860.20, with R&D expenses accounting for 26.39% of operating revenue, a decrease of 11.72 percentage points[5] - Research and development expenses for Q1 2025 were ¥35.44 million, down 19% from ¥43.79 million in Q1 2024[20] Operational Strategy - The company plans to continue focusing on improving operational efficiency and reducing costs to enhance profitability in future quarters[7] Shareholder and Financing Activities - The company has no significant changes in the shareholder structure or related party transactions during the reporting period[12] - The company raised ¥60 million through borrowings in Q1 2025, compared to ¥40 million in Q1 2024, reflecting increased financing activities[24] - Cash flow from financing activities totaled $48,362,784.97, an increase from $28,466,172.98 in the previous period, reflecting a growth of approximately 70.0%[25]

证券代码：688600 证券简称：皖仪科技 公告编号：2025-024 安徽皖仪科技股份有限公司（以下简称"公司"）第五届监事会第十六次会 议于 2025 年 4 月 24 日以通讯方式召开，会议通知已于 2025 年 4 月 22 日以电话、 短信及口头等方式送达公司全体监事。根据《公司章程》《监事会会议事规则》 相关规定，全体监事一致同意豁免本次监事会会议提前 5 日的通知期限。本次会 议由监事会主席王国东先生主持，会议应出席监事 3 人，实际出席监事 3 人。本 次会议的召集、召开符合《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）等法律、法规和《安徽 皖仪科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定。 二、监事会会议审议情况 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 安徽皖仪科技股份有限公司 第五届监事会第十六次会议决议公告 一、监事会会议召开情况 综上，监事会认为公司和激励对象均未发生不得授予限制性股票的情形，本 次激励计划规定的授予条 ...

证券代码：688600 证券简称：皖仪科技 公告编号：2025-023 安徽皖仪科技股份有限公司 第五届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 安徽皖仪科技股份有限公司（以下简称"公司"）第五届董事会第二十一次会议 于 2025 年 4 月 24 日以通讯方式召开，会议通知已于 2025 年 4 月 22 日以电话、短 信及书面等方式送达公司全体董事。根据《公司章程》《董事会议事规则》相关规定， 全体董事一致同意豁免本次董事会会议提前 5 日的通知期限。会议由董事长臧牧先 生主持。本次会议应出席董事 6 人，实际出席董事 6 人。本次会议的召集、召开符 合《中华人民共和国公司法》等法律、法规和《公司章程》的有关规定。 二、董事会会议审议情况 1、审议通过《关于向 2025 年限制性股票激励计划激励对象首次授予限制性股 票的议案》 根据《上市公司股权激励管理办法》、公司《激励计划（草案）》及其摘要的相 关规定和公司 2025 年第二次临时股东大会的授权，董事会认为 ...

安徽皖仪科技股份有限公司（以下简称"公司"）监事会根据《中华人民共 和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称 "《证券法》"）、《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《上 海证券交易所科创板股票上市规则》（以下简称"《上市规则》"）、《上海证券交 易所上市公司自律监管指引第 1 号——规范运作》《科创板上市公司自律监管指 南第 4 号——股权激励信息披露》等相关法律法规及规范性文件和《公司章程》 的有关规定，对公司 2025 年限制性股票激励计划（以下简称"本次激励计划"） 首次授予激励对象名单（首次授予日）进行了核查，现发表核查意见如下： 一、本次激励计划首次授予激励对象均不存在《上市公司股权激励管理办 法》规定的不得成为激励对象的情形： 1、最近 12 个月内被证券交易所认定为不适当人选； 2、最近 12 个月内被中国证监会及其派出机构认定为不适当人选； 安徽皖仪科技股份有限公司监事会 关于公司 2025 年限制性股票激励计划首次授予 激励对象名单的核查意见（首次授予日） 5、法律法规规定不得参与上市公司股权激励的； 6、中国证监会认定的其他情形。 二 ...